Stewart Alan R. has filed 15 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 137078 shares of Calidi Biotherapeutics, Inc. ($CLDI) on July 09, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 9, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Stewart Alan R. | Director | A | Non-Qualified Stock Options (right to buy) | 137078 | $0.00 | 137,078.0000 | 28,467,580 | 9999.99% | 0.48% |
| Feb. 28, 2025 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 5000 | $16.22 | 174,013.0000 | 12,634,485 | 2.79% | 0.04% |
| Feb. 28, 2025 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 36312 | $0.00 | 179,013.0000 | 12,634,485 | 25.45% | 0.29% |
| Feb. 28, 2025 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 4750 | $16.11 | 174,013.0000 | 12,634,485 | 2.66% | 0.04% |
| Dec. 31, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Stewart Alan R. | Director | A | Common Stock | 12771 | $0.00 | 28,976.0000 | 0 | 78.81% | 0.00% |
| Dec. 10, 2024 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | Chief Financial Officer | S | Common Stock | 15000 | $13.95 | 147,451.0000 | 12,761,448 | 9.23% | 0.12% |
| Sept. 20, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Stewart Alan R. | Director | A | Non-Qualified Stock Options (right to buy) | 20217 | $0.00 | 20,217.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Stewart Alan R. | Director | A | Common Stock | 73437 | $0.00 | 154,087.0000 | 0 | 91.06% | 0.00% |
| March 29, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Stewart Alan R. | Director | A | Common Stock | 25995 | $0.00 | 80,650.0000 | 0 | 47.56% | 0.00% |
| May 17, 2024 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | Chief Financial Officer | A | Common Stock | 1032 | $14.18 | 154,294.0000 | 12,761,448 | 0.67% | 0.01% |
| May 17, 2024 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | Chief Financial Officer | A | Common Stock | 3276 | $14.30 | 157,570.0000 | 12,761,448 | 2.12% | 0.03% |
| May 20, 2024 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | Chief Financial Officer | A | Common Stock | 3000 | $14.46 | 160,570.0000 | 12,761,448 | 1.90% | 0.02% |
| March 1, 2024 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 24295 | $0.00 | 153,262.0000 | 12,761,448 | 18.84% | 0.19% |
| Jan. 30, 2024 | SOUNDTHINKING, INC. | $SSTI | Stewart Alan R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 8111 | $0.00 | 128,967.0000 | 12,761,448 | 6.71% | 0.06% |
| Dec. 21, 2023 | Calidi Biotherapeutics, Inc. | $CLDI | Stewart Alan R. | Director | A | Common Stock | 7282 | $1.80 | 54,655.0000 | 0 | 15.37% | 0.00% |